" by picking cells that have successfully repaired the damaged gene we intended to fix , we might inadvertently also pick cells without functional p53 , " study author emma haapaniemi from the karolinska institute explained . " if transplanted into a patient , as in gene therapy for inherited diseases , such cells could give rise to cancer , raising concerns for the safety of crispr - based gene therapies . "